| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Common Stock | Options Exercise | $558,180 | +14,000 | +22222% | $39.87 | 14,063 | 04 Nov 2021 | Direct | |
| transaction | CNMD | Common Stock | Sale | $2,156,854 | -14,000 | -100% | $154.06 | 63 | 04 Nov 2021 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -14,000 | -84% | $0.000000 | 2,700 | 04 Nov 2021 | Common Stock | 14,000 | $39.87 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.00 to $154.58. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F2 | The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |